Loss of Diacylglycerol Kinase-Ζ Inhibits Cell Proliferation and Survival in Human Gliomas

[1]  D. A. Foster,et al.  Regulation of mTOR by phosphatidic acid? , 2007, Cancer Research.

[2]  K. Henkels,et al.  Phosphatidic Acid Increases Epidermal Growth Factor Receptor Expression by Stabilizing mRNA Decay and by Inhibiting Lysosomal and Proteasomal Degradation of the Internalized Receptor , 2015, Molecular and Cellular Biology.

[3]  D. A. Foster,et al.  Phospholipase D and the Maintenance of Phosphatidic Acid Levels for Regulation of Mammalian Target of Rapamycin (mTOR)* , 2014, The Journal of Biological Chemistry.

[4]  Y. Shirai,et al.  Diacylglycerol kinase as a possible therapeutic target for neuronal diseases , 2014, Journal of Biomedical Science.

[5]  H. Hara,et al.  The roles of diacylglycerol kinases in the central nervous system: review of genetic studies in mice. , 2014, Journal of pharmacological sciences.

[6]  S. Gee,et al.  Increased diacylglycerol kinase ζ expression in human metastatic colon cancer cells augments Rho GTPase activity and contributes to enhanced invasion , 2014, BMC Cancer.

[7]  Kaleigh Fernald,et al.  Evading apoptosis in cancer. , 2013, Trends in cell biology.

[8]  B. Kefas,et al.  A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival. , 2013, Neuro-oncology.

[9]  L. Deangelis,et al.  Glioblastoma and other malignant gliomas: a clinical review. , 2013, JAMA.

[10]  D. Haussler,et al.  The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.

[11]  Mitsuyoshi Iino,et al.  Cytoplasmic localization of DGK&zgr; exerts a protective effect against p53-mediated cytotoxicity , 2013, Journal of Cell Science.

[12]  G. M. Wilson,et al.  Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers. , 2013, Cancer discovery.

[13]  R. Jenkins,et al.  Genetics of adult glioma. , 2012, Cancer genetics.

[14]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[15]  Toshiaki Tanaka,et al.  DGKζ is degraded through the cytoplasmic ubiquitin-proteasome system under excitotoxic conditions, which causes neuronal apoptosis because of aberrant cell cycle reentry. , 2012, Cellular signalling.

[16]  J. Mpindi,et al.  HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation , 2012, Oncogene.

[17]  Philip Hahnfeldt,et al.  Cancer stem cells in solid tumors: is 'evading apoptosis' a hallmark of cancer? , 2011, Progress in biophysics and molecular biology.

[18]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[19]  W. Jiang,et al.  iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway , 2010, BMC Cancer.

[20]  H. Nagawa,et al.  Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells , 2010, BMC Cancer.

[21]  L. Stein,et al.  A human functional protein interaction network and its application to cancer data analysis , 2010, Genome Biology.

[22]  Steven Piantadosi,et al.  Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States , 2010, Clinical Cancer Research.

[23]  K. Shokat,et al.  Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. , 2010, Cancer cell.

[24]  J. McCubrey,et al.  Identification of a functional nuclear export sequence in diacyl glycerol kinase-ζ , 2010 .

[25]  A. Martelli,et al.  TIS21/BTG2/PC3 and cyclin D1 are key determinants of nuclear diacylglycerol kinase-zeta-dependent cell cycle arrest. , 2009, Cellular signalling.

[26]  Gordon B. Mills,et al.  Derailed endocytosis: an emerging feature of cancer , 2008, Nature Reviews Cancer.

[27]  L. Trusolino,et al.  Drug development of MET inhibitors: targeting oncogene addiction and expedience , 2008, Nature Reviews Drug Discovery.

[28]  B. K. Park,et al.  MDM2 regulates dihydrofolate reductase activity through monoubiquitination. , 2008, Cancer research.

[29]  Zhi-xiang Shen,et al.  Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia , 2008, Proceedings of the National Academy of Sciences.

[30]  M. Ashcroft,et al.  Regulation of angiogenic factors by HDM2 in renal cell carcinoma. , 2008, Cancer research.

[31]  A. Martelli,et al.  Nuclear diacylglycerol kinase‐ζ is a negative regulator of cell cycle progression in C2C12 mouse myoblasts , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[33]  I. Mérida,et al.  Proteomics identification of sorting nexin 27 as a diacylglycerol kinase zeta-associated protein: new diacylglycerol kinase roles in endocytic recycling. , 2007, Molecular & cellular proteomics : MCP.

[34]  Guido Kroemer,et al.  Lysosomes and autophagy in cell death control , 2005, Nature Reviews Cancer.

[35]  E. Gelmann,et al.  The ubiquitin-proteasome pathway and its role in cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Neil O. Carragher,et al.  The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.

[37]  Y. Hozumi,et al.  Nuclear localization of diacylglycerol kinase ζ in neurons , 2003, The European journal of neuroscience.

[38]  F. Davis,et al.  Epidemiology of brain tumors. , 2000, Current opinion in neurology.

[39]  P. Blackshear,et al.  Protein kinase C regulates the nuclear localization of diacylglycerol kinase-ζ , 1998, Nature.

[40]  Bert Vogelstein,et al.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.

[41]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[42]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. , 2013, Neuro-oncology.

[43]  K. Cai.  Title : Increased Diacylglycerol Kinase zeta Expression in Human Metastatic Colon Cancer Cells Augments Rho GTPase Activity and Contributes to Enhanced Invasion , 2013 .

[44]  I. Mérida,et al.  Diacylglycerol kinase ζ: at the crossroads of lipid signaling and protein complex organization. , 2012, Progress in lipid research.

[45]  J. McCubrey,et al.  Identification of a functional nuclear export sequence in diacylglycerol kinase-zeta. , 2010, Cell cycle.

[46]  T. Nielsen,et al.  MDM2 protein expression is a negative prognostic marker in breast carcinoma , 2006, Modern Pathology.

[47]  Y. Hozumi,et al.  Nuclear localization of diacylglycerol kinase zeta in neurons. , 2003, The European journal of neuroscience.

[48]  P. Blackshear,et al.  Protein kinase C regulates the nuclear localization of diacylglycerol kinase-zeta. , 1998, Nature.